VERTEX PHARMACEUTICALS INC / MA (VRTX) › Shares OutstandingVERTEX PHARMACEUTICALS INC / MA (VRTX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2008: 140.56M2009: 173.26M2010: 200.40M2011: 208.81M2012: 215.26M2013: 224.91M2014: 235.31M2015: 241.31M2016: 244.69M2017: 253.22M2018: 259.19M2019: 260.70M2020: 263.40M2021: 259.90M2022: 259.10M2023: 260.50M2024: 257.90M2025: 258.00M258.00M2008Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025258.00M+0.0%2024257.90M-1.0%2023260.50M+0.5%2022259.10M-0.3%2021259.90M-1.3%2020263.40M+1.0%2019260.70M+0.6%2018259.19M+2.4%2017253.22M+3.5%2016244.69M+1.4%2015241.31M+2.6%2014235.31M+4.6%2013224.91M+4.5%2012215.26M+3.1%2011208.81M+4.2%2010200.40M+15.7%2009173.26M+23.3%2008140.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share